Sandra Acholonu

1.2k total citations
18 papers, 834 citations indexed

About

Sandra Acholonu is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, Sandra Acholonu has authored 18 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Sandra Acholonu's work include Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Viral-associated cancers and disorders (5 papers). Sandra Acholonu is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Viral-associated cancers and disorders (5 papers). Sandra Acholonu collaborates with scholars based in United States and United Kingdom. Sandra Acholonu's co-authors include Issa F. Khouri, Richard E. Champlin, Rima M. Saliba, Barbara Pro, Chitra Hosing, Peter McLaughlin, Anas Younes, Michèle L. Donato, Sergio Giralt and Luis Fayad and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sandra Acholonu

18 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Acholonu United States	12	601	479	252	219	210	18	834
Alain Devidas France	9	487 0.8×	345 0.7×	87 0.3×	180 0.8×	204 1.0×	14	725
MJ Brisco Australia	9	342 0.6×	228 0.5×	191 0.8×	229 1.0×	172 0.8×	9	706
ES Jaffe United States	13	749 1.2×	513 1.1×	68 0.3×	385 1.8×	215 1.0×	18	995
Emilienne Kühlein France	16	282 0.5×	236 0.5×	278 1.1×	223 1.0×	267 1.3×	30	850
Lucile Couronné France	13	466 0.8×	293 0.6×	111 0.4×	161 0.7×	250 1.2×	31	843
Craig C. Childs United States	17	407 0.7×	301 0.6×	308 1.2×	374 1.7×	209 1.0×	25	911
Lekidelu Taddesse-Heath United States	12	486 0.8×	491 1.0×	64 0.3×	160 0.7×	164 0.8×	21	795
R E Hutchison United States	9	468 0.8×	244 0.5×	59 0.2×	172 0.8×	169 0.8×	14	598
Pramoda Challagundla United States	10	356 0.6×	223 0.5×	168 0.7×	264 1.2×	346 1.6×	15	742
K L Chang United States	7	302 0.5×	362 0.8×	72 0.3×	65 0.3×	86 0.4×	8	620

Countries citing papers authored by Sandra Acholonu

Since Specialization

Citations

This map shows the geographic impact of Sandra Acholonu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Acholonu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Acholonu more than expected).

Fields of papers citing papers by Sandra Acholonu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Acholonu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Acholonu. The network helps show where Sandra Acholonu may publish in the future.

Co-authorship network of co-authors of Sandra Acholonu

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Acholonu. A scholar is included among the top collaborators of Sandra Acholonu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Acholonu. Sandra Acholonu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Duvic, Madeleine, Michèle L. Donato, Bouthaina S. Dabaja, et al.. (2010). Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome. Journal of Clinical Oncology. 28(14). 2365–2372. 107 indexed citations

Anderlini, Paolo, Sandra Acholonu, Sergio Giralt, et al.. (2008). Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience. Haematologica. 93(2). 257–264. 94 indexed citations

Hosing, Chitra, Rima M. Saliba, Martin Körbling, et al.. (2006). High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma. Leukemia & lymphoma. 47(7). 1290–1294. 8 indexed citations

Hosing, Chitra, Michele Donato, Issa F. Khouri, et al.. (2006). Allogeneic hematopoietic stem cell transplantation for cutaneous T-cell lymphoma (CTCL). Journal of Clinical Oncology. 24(18_suppl). 7540–7540. 1 indexed citations

Anderlini, Paolo, Rima M. Saliba, Sandra Acholonu, et al.. (2006). Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.. Blood. 108(11). 3115–3115. 1 indexed citations

Anderlini, Paolo, Rima M. Saliba, Sandra Acholonu, et al.. (2005). Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplantation. 35(10). 943–951. 86 indexed citations

Khouri, Issa F., et al.. (2005). Non-Myeloablative Allogeneic Transplantation (NMT) with T-Cell Replete Graft for Relapsed Chemosensitive Follicular Lymphoma (FL): Donor Lymphocyte Infusion (DLI) To Convert Stable Mixed Chimerism to Full Donor Chimerism Is Not Necessary in the Absence of Disease Progression.. Blood. 106(11). 3659–3659. 3 indexed citations

Khouri, Issa F., Rima M. Saliba, Chitra Hosing, et al.. (2005). Autologous Stem Cell (AUTO) vs Non-Myeloablative Allogeneic Transplantation (NMT) after High-Dose Rituximab (HD-R) -Containing Conditioning Regimens for Relapsed Chemosensitve Follicular Lymphoma (FL).. Blood. 106(11). 48–48. 11 indexed citations

Khouri, Issa F., Rima M. Saliba, Chitra Hosing, et al.. (2005). Concurrent Administration of High-Dose Rituximab Before and After Autologous Stem-Cell Transplantation for Relapsed Aggressive B-Cell Non-Hodgkin’s Lymphomas. Journal of Clinical Oncology. 23(10). 2240–2247. 97 indexed citations

10.

Anderlini, Paolo, Sandra Acholonu, Börje S. Andersson, et al.. (2004). Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response. Bone Marrow Transplantation. 34(6). 511–514. 34 indexed citations

11.

Anderlini, Paolo, Sandra Acholonu, Grace‐Julia Okoroji, et al.. (2004). Immunotherapy with Donor Leukocyte Infusions (DLIS) in Relapsed Hodgkin’s Disease (HD) Following Allogeneic Stem Cell Transplantation (ALLO-SCT): CD3+ Cell Dose, GVHD and Disease Response.. Blood. 104(11). 1654–1654. 1 indexed citations

12.

Escalón, Maricer P., Richard E. Champlin, Rima M. Saliba, et al.. (2004). Nonmyeloablative Allogeneic Hematopoietic Transplantation: A Promising Salvage Therapy for Patients With Non-Hodgkin's Lymphoma Whose Disease Has Failed a Prior Autologous Transplantation. Journal of Clinical Oncology. 22(12). 2419–2423. 79 indexed citations

13.

Khouri, Issa F., Rima M. Saliba, Grace‐Julia Okoroji, Sandra Acholonu, & Richard E. Champlin. (2003). Long‐term follow‐up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission. Cancer. 98(12). 2630–2635. 68 indexed citations

14.

Khouri, Issa F., Rima M. Saliba, Jun Gu, et al.. (2003). Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell Lymphoma. Journal of Clinical Oncology. 21(23). 4407–4412. 153 indexed citations

15.

Anderlini, Paolo, Sandra Acholonu, Grace‐Julia Okoroji, et al.. (2003). 26 Reduced early transplant-related mortality following allogeneic stem cell transplantation (SCT) with fludarabine-based, reduced-intensity conditioning from matched related and unrelated donors in advanced Hodgkin's disease (HD). Biology of Blood and Marrow Transplantation. 9(2). 71–71. 2 indexed citations

16.

Anderlini, P, Sergio Giralt, Börje S. Andersson, et al.. (2000). Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease. Bone Marrow Transplantation. 26(6). 615–620. 66 indexed citations

17.

Ofori, Kwame Simpe, Sandra Acholonu, André Miller, et al.. (1995). Schistosoma mansoni: Changes in the Albumen Gland of Biomphalaria glabrata Snails Selected for Nonsusceptibility to the Parasite. Journal of Parasitology. 81(6). 905–905. 11 indexed citations

18.

Ofori, Kwame Simpe, Sandra Acholonu, André Miller, et al.. (1995). Schistosoma mansoni: changes in the albumen gland of Biomphalaria glabrata snails selected for nonsusceptibility to the parasite.. PubMed. 81(6). 905–11. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact